Upcoming Clinical Trials:


  • ALXN2040-GA-201- A  Phase 2, Double-Masked, Placebo- Controlled, Dose Range Finding Study of Danicopan (ALXN2040) in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)


  • NOPRODRPG0002 Global Patient Registry of Inherited Retinal Disease with XLRP and ACHM


  • A Randomized Clinical Trial Evaluating Intravitreal Faricimab (6.0mg) Injections or Fluocinolone Acetonide (0.19mg) Intravitreal Implants vs Observation for Prevention of Visual Acuity Loss due to Radiation Retinopathy (Protocol AL)


  • A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions of Small Choroidal Melanoma